Last reviewed · How we verify
NCT03400514: W001
Clinical Concordance Study Between Watson for Oncology and Clinician Practice
trial in Cancer in 350 participants. Status unknown.
31 December 2018
Quick facts
| Lead sponsor | Qingdao University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 350 |
| Start date | 12 April 2017 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 January 2019 |
| Sites | 1 location across China |
Conditions studied
- Cancer — all drugs for Cancer →
- Artificial Intelligence — all drugs for Artificial Intelligence →
Sponsor
Qingdao University
Who can join
Adults 18 to 90, any sex, with Cancer or Artificial Intelligence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a double-blind study involving 362 patients in India, treatment recommendations from Watson for Oncology (WFO) performed a high degree of consistency with their multidisciplinary tumor board. The investigators would recruit cancer patients diagnosed as lung cancer, breast cancer, gastric cancer, colon cancer， rectal cancer，cervical cancer or ovarian cancer according to the criteria of Watson for Oncology ，using the updated version of Watson for Oncology to explore the concordance of therapeutic regimen between WFO and physicians in the Affiliated Hospital of Qingdao University.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.
Zhou N, Zhang CT, Lv HY, Hao CX, et al · · 2019 · cited 80× · PMID 30181315 · DOI 10.1634/theoncologist.2018-0255
Verify or expand the search:
- PubMed search for NCT03400514
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Qingdao University trials
Trials by the same sponsor.
- NCT06359977 — The Effect of Quantitative EEG Combined With Ultrasound and Sputum Volume on Predicting Weaning Failure · not yet recruiting
- NCT06083831 — The Effect of Sequential Feeding for Circadian Rhythm and Gut Flora Rhythm in Critically Ill Patients · unknown
- NCT05842993 — Study of Hydrogen Inhalation Compared With Placebo in Type 2 Diabetes Patients · NA · unknown
- NCT05905588 — Study of Hydrogen-rich Water Compared With Placebo in Type 2 Diabetes Patients · NA · unknown
- NCT04443335 — Comparison of Continuous Feeding and Sequential Feeding on Gut Microbiota and Metabolomics in Critically Ill Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03400514 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qingdao University
- Last refreshed: 18 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03400514.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing